笔趣阁

手机浏览器扫描二维码访问

参 考 文 献（第2页）

22.MehtaRL，McDonaldBR，AguilarMM，etal.Regionalcitrateanticoagulationforcontinuousarteriovenoushemodialysisincriticallyillpatients.KidneyInt，1990，38（5）：976-981

23.ClarkJA，SchulmanG，GolperTA.Safetyandefficacyofregionalcitrateanticoagulationduring8-hoursustainedlow-efficiencydialysis.ClinJAmSocNephrol，2008，3（3）：736-742

24.WuMY，HsuYH，BaiCH，etal.Regionalcitrateversusheparinanticoagulationforcontinuousrenalreplacementtherapy：ameta-analysisofrandomizedcontrolledtrials.AmJKidneyDis，2012，59（6）：810-818

25.Oudemans-vanStraatenHM，KellumJA，BellomoR.Clinicalreview：anticoagulationforcontinuousrenalreplacementtherapy—heparinorcitrate？CritCare，2011，15（1）：202

26.ParkJ-S，KimG-H，KangCM，etal.Regionalanticoagulationwithcitrateissuperiortosystemicanticoagulationwithheparinincriticallyillpatientsundergoingcontinuousvenovenoushemodiafiltration.KoreanJInternMed，2011，26（1）：68-75

27.KutsogiannisDJ，GibneyRT，StolleryD，etal.Regionalcitrateversussystemicheparinanticoagulationforcontinuousrenalreplacementincriticallyillpatients.KidneyInt，2005，67（6）：2361-2367

28.O’ReillyP，TolwaniA.RenalreplacementtherapyⅢ：IHD，CRRT，SLED.CritCareClin，2005，21（2）：367-378

29.CongerJ.Dialysisandrelatedtherapies.SeminNephrol，1998，18（5）：533-540

30.BrigliaA，PaganiniEP.Acuterenalfailureintheintensivecareunit.Therapyoverview，patientriskstratification，plicationsofrenalreplacement，andspecialcircumstances.ClinChestMed，1999，20（2）：347-366

31.EmiliS，BlackNA，PaulRV，etal.Aprotocol-basedtreatmentforintradialytichypotensioninhospitalizedhemodialysispatients.AmJKidneyDis，1999，33（6）：1107-1114

32.MarshallMR，MaT，GallerD，etal.Sustainedlow-efficiencydailydiafiltration（SLEDD-f）forcriticallyillpatientsrequiringrenalreplacementtherapy：towardsanadequatetherapy.NephrolDialTransplant，2004，19（4）：877-884

33.AlamM，MarshallM，ShaverM，etal.Costparisonbetweensustainedlowefficiencyhemodialysis（SLED）andcontinuousvenovenoushemofiltration（CVVH）forICUpatientswithARF（abstract）.AmJKidneyDis，2000，35：A9

34.MaT，WalkerR，EggletonK，etal.Costparisonbetweensustainedlowefficiencydialysisdiafiltration（SLEDD）andcontinuousrenalreplacementtherapyforICUpatientswithARF（abstract）.Nephrology，2002，7：A54

35.BerbeceA，RichardsonR.Sustainedlow-efficiencydialysisintheICU：cost，anticoagulation，andsoluteremoval.KidneyInt，2006，70（5）：963-968

36.KumarVA，YeunJY，DepnerTA，etal.Extendeddailydialysisvs.continuoushemodialysisforICUpatientswithacuterenalfailure：atwo-yearsinglecenterreport.IntJArtifOrgans，2004，27（5）：371-379

37.MarshallMR，MaT，GallerD，etal.Sustainedlow-efficiencydailydiafiltration（SLEDD-f）forcriticallyillpatientsrequiringrenalreplacementtherapy：towardsanadequatetherapy.NephrolDialTransplant，2004，19（4）：877-884

38.HoltBG，WhiteJJ，KuthialaA，etal.Sustainedlow-efficiencydailydialysiswithhemofiltrationforacutekidneyinjuryinthepresenceofsepsis.ClinNephrol，2008，69（1）：40-46

39.SalahudeenAK，KumarV，MadanN，etal.Sustainedlowefficiencydialysisinthecontinuousmode（C-SLED）：dialysisefficacy，clinicaloutes，andsurvivalpredictorsincriticallyillcancerpatients.ClinJAmSocNephrol，2009，4（8）：1338-1346

40.RoncoC，BrendolanA，LonnemannG，etal.Apilotstudyofcoupledplasmafiltrationwithadsorptioninsepticshock.CritCareMed，2002，30（6）：1250-1255

41.TumlinJ，WaliR，WilliamsW，etal.Efficacyandsafetyofrenaltubulecelltherapyforacuterenalfailure.JAmSocNephrol，2008，19（5）：1034-1040

42.CruzDN，AntonelliM，FumagalliR，etal.EarlyuseofpolymyxinBhemoperfusioninabdominalsepticshock：theEUPHASrandomizedcontrolledtrial.JAMA，2009，301（23）：2445-2452

43.WeiQ，BaihaiS，PingF，etal.Successfultreatmentofcrushsyndromeplicatedwithmultipleorgandysfunctionsyndromeusinghybridcontinuousrenalreplacementtherapy.BloodPurif，2009，28（3）：175-180

44.ZhangL，LiZ，FuP，etal.Hybridrenalreplacementtreatmentinacutepulmonaryedemawithacutekidneyinjuryfollowingmultiplewaspstings：areportof3cases.BloodPurif，2010，30（2）：106-107